(Q39397971)

11 September 2017

title

A pilot study of the beneficial effects of amantadine in the treatment of painful diabetic peripheral neuropathy (English)

1 reference

11 September 2017

Amin P

1

1 reference

11 September 2017

Sturrock ND

series ordinal

2

1 reference

11 September 2017

publication date

1 February 2003

1 reference

11 September 2017

1 reference

11 September 2017

volume

20

1 reference

11 September 2017

issue

2

1 reference

11 September 2017

page(s)

114-118

1 reference

Neuropathic pain in cancer patients: mechanisms, syndromes, and clinical controversies

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00882.X

Diabetic peripheral neuropathy and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00882.X

A systematic review of antidepressants in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00882.X

The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00882.X

Ketamine hydrochloride in the treatment of phantom limb pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00882.X

Response of chronic neuropathic pain syndromes to ketamine: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00882.X

High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00882.X

Therapeutic brain concentration of the NMDA receptor antagonist amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00882.X

Diverse sensory functions with an almost totally divided spinal cord. A case of spinal cord transection with preservation of part of one anterolateral quadrant

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00882.X

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00882.X

Can patients with chronic neuropathic pain be cured by acute administration of the NMDA receptor antagonist amantadine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00882.X

Amantadine is beneficial in restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00882.X

Investigation on possible antioxidative properties of the NMDA-receptor antagonists ketamine, memantine, and amantadine in comparison to nicanartine in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00882.X

Graphic representation of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00882.X

Studies with different types of visual analog scales for measurement of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00882.X

10.1046/J.1464-5491.2003.00882.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference